A decade of transformation in MASLD: from nomenclature to novel therapies.

Schattenberg JM, Noureddin M

Open source

DOI
10.1016/s2468-1253(26)00087-7
Published
2026 Sep
Container
The lancet. Gastroenterology & hepatology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2468-1253-26-00087-7,
  title = {A decade of transformation in MASLD: from nomenclature to novel therapies.},
  author = {Schattenberg JM and Noureddin M},
  year = {2026},
  journal = {The lancet. Gastroenterology \& hepatology},
  doi = {10.1016/s2468-1253(26)00087-7},
  url = {https://doi.org/10.1016/s2468-1253(26)00087-7}
}

RIS

TY  - JOUR
TI  - A decade of transformation in MASLD: from nomenclature to novel therapies.
AU  - Schattenberg JM
AU  - Noureddin M
PY  - 2026
JO  - The lancet. Gastroenterology & hepatology
DO  - 10.1016/s2468-1253(26)00087-7
UR  - https://doi.org/10.1016/s2468-1253(26)00087-7
ER  - 

APA

JM, S., & M, N. (2026). A decade of transformation in MASLD: from nomenclature to novel therapies.. The lancet. Gastroenterology & hepatology. https://doi.org/10.1016/s2468-1253(26)00087-7

Source records